Brief: Lumibird 9-Month Revenue Up 9.6% To EUR 155.1 Million
27/10/2025 17:30
Oct 27 (Reuters) - Lumibird SA LBIRD.PA: REVENUE FOR THE FIRST NINE MONTHS UP 9.6% TO EUR 155.1 MILLION MEDICAL DIVISION'S BUSINESS REMAINED STABLE AT CONSTANT EXCHANGE RATES OVER QUARTER, DUE TO DELIVERY DELAYS POSTPONED TO Q4 2025 AS EVERY YEAR, LUMIBIRD ANTICIPATES A VERY HIGH LEVEL OF ACTIVITY IN Q4 Source text: ID:nACT94834 Further company coverage: LBIRD.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lumibird SA
See all newsBrief: Lumibird - H1 Net Income Up +4.5% To EUR 5.1 Million
Brief: Lumibird Signs A Share Purchase Agreement For The Sale Of Lumibird Medical To IPG Photonics Corporation
Brief: Lumibird H1 Revenue Up +9.7% Lfl to €114.7 Mln
Brief: Lumibird Signs Agreement With Cilas
Brief: Lumibird Enters Into Exclusive Negotiations For The Sale Of Its Medical Division To IPG Photonics Corporation